Global Kidney Cancer Drug Sales Market Report 2016

Publisher Name :
Date: 19-Sep-2016
No. of pages: 120
Inquire Before Buying

Notes:

Sales, means the sales volume of Kidney Cancer Drug

Revenue, means the sales value of Kidney Cancer Drug

This report studies sales (consumption) of Kidney Cancer Drug in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

- Bayer

- F. Hoffmann-La Roche

- GlaxoSmithKline

- Novartis

- Pfizer

- Abbott Laboratories

- Active Biotech

- Amgen

- Argos Therapeutics

- ArQule

- AVEO Pharmaceuticals

- Bionomics

- Bristol-Myers Squibb

- Cerulean Pharma

- Exelixis

- Genentech

- immatics biotechnologies

- Immunicum

- Ono Pharmaceutical

- Onyx Therapeutics

- Oxford BioMedica

- Prometheus Laboratories

- Seattle Genetics

- Taiwan Liposome

- TRACON Pharmaceuticals

- Wilex

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Kidney Cancer Drug in these regions, from 2011 to 2021 (forecast), like

- USA

- China

- Europe

- Japan

- India

- Southeast Asia

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Kidney Cancer Drug in each application, can be divided into

- Application 1

- Application 2

- Application 3

Global Kidney Cancer Drug Sales Market Report 2016

Table of Contents
Global Kidney Cancer Drug Sales Market Report 2016
1 Kidney Cancer Drug Overview
1.1 Product Overview and Scope of Kidney Cancer Drug
1.2 Classification of Kidney Cancer Drug
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Kidney Cancer Drug
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 Kidney Cancer Drug Market by Regions
1.4.1 USA Status and Prospect (2011-2021)
1.4.2 China Status and Prospect (2011-2021)
1.4.3 Europe Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 India Status and Prospect (2011-2021)
1.4.6 Southeast Asia Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Kidney Cancer Drug (2011-2021)
1.5.1 Global Kidney Cancer Drug Sales and Growth Rate (2011-2021)
1.5.2 Global Kidney Cancer Drug Revenue and Growth Rate (2011-2021)
2 Global Kidney Cancer Drug Competition by Manufacturers, Type and Application
2.1 Global Kidney Cancer Drug Market Competition by Manufacturers
2.1.1 Global Kidney Cancer Drug Sales and Market Share of Key Manufacturers (2011-2016)
2.1.2 Global Kidney Cancer Drug Revenue and Share by Manufacturers (2011-2016)
2.2 Global Kidney Cancer Drug (Volume and Value) by Type
2.2.1 Global Kidney Cancer Drug Sales and Market Share by Type (2011-2016)
2.2.2 Global Kidney Cancer Drug Revenue and Market Share by Type (2011-2016)
2.3 Global Kidney Cancer Drug (Volume and Value) by Regions
2.3.1 Global Kidney Cancer Drug Sales and Market Share by Regions (2011-2016)
2.3.2 Global Kidney Cancer Drug Revenue and Market Share by Regions (2011-2016)
2.4 Global Kidney Cancer Drug (Volume) by Application
3 USA Kidney Cancer Drug (Volume, Value and Sales Price)
3.1 USA Kidney Cancer Drug Sales and Value (2011-2016)
3.1.1 USA Kidney Cancer Drug Sales and Growth Rate (2011-2016)
3.1.2 USA Kidney Cancer Drug Revenue and Growth Rate (2011-2016)
3.1.3 USA Kidney Cancer Drug Sales Price Trend (2011-2016)
3.2 USA Kidney Cancer Drug Sales and Market Share by Manufacturers
3.3 USA Kidney Cancer Drug Sales and Market Share by Type
3.4 USA Kidney Cancer Drug Sales and Market Share by Application
4 China Kidney Cancer Drug (Volume, Value and Sales Price)
4.1 China Kidney Cancer Drug Sales and Value (2011-2016)
4.1.1 China Kidney Cancer Drug Sales and Growth Rate (2011-2016)
4.1.2 China Kidney Cancer Drug Revenue and Growth Rate (2011-2016)
4.1.3 China Kidney Cancer Drug Sales Price Trend (2011-2016)
4.2 China Kidney Cancer Drug Sales and Market Share by Manufacturers
4.3 China Kidney Cancer Drug Sales and Market Share by Type
4.4 China Kidney Cancer Drug Sales and Market Share by Application
5 Europe Kidney Cancer Drug (Volume, Value and Sales Price)
5.1 Europe Kidney Cancer Drug Sales and Value (2011-2016)
5.1.1 Europe Kidney Cancer Drug Sales and Growth Rate (2011-2016)
5.1.2 Europe Kidney Cancer Drug Revenue and Growth Rate (2011-2016)
5.1.3 Europe Kidney Cancer Drug Sales Price Trend (2011-2016)
5.2 Europe Kidney Cancer Drug Sales and Market Share by Manufacturers
5.3 Europe Kidney Cancer Drug Sales and Market Share by Type
5.4 Europe Kidney Cancer Drug Sales and Market Share by Application
6 Japan Kidney Cancer Drug (Volume, Value and Sales Price)
6.1 Japan Kidney Cancer Drug Sales and Value (2011-2016)
6.1.1 Japan Kidney Cancer Drug Sales and Growth Rate (2011-2016)
6.1.2 Japan Kidney Cancer Drug Revenue and Growth Rate (2011-2016)
6.1.3 Japan Kidney Cancer Drug Sales Price Trend (2011-2016)
6.2 Japan Kidney Cancer Drug Sales and Market Share by Manufacturers
6.3 Japan Kidney Cancer Drug Sales and Market Share by Type
6.4 Japan Kidney Cancer Drug Sales and Market Share by Application
7 India Kidney Cancer Drug (Volume, Value and Sales Price)
7.1 India Kidney Cancer Drug Sales and Value (2011-2016)
7.1.1 India Kidney Cancer Drug Sales and Growth Rate (2011-2016)
7.1.2 India Kidney Cancer Drug Revenue and Growth Rate (2011-2016)
7.1.3 India Kidney Cancer Drug Sales Price Trend (2011-2016)
7.2 India Kidney Cancer Drug Sales and Market Share by Manufacturers
7.3 India Kidney Cancer Drug Sales and Market Share by Type
7.4 India Kidney Cancer Drug Sales and Market Share by Application
8 Southeast Asia Kidney Cancer Drug (Volume, Value and Sales Price)
8.1 Southeast Asia Kidney Cancer Drug Sales and Value (2011-2016)
8.1.1 Southeast Asia Kidney Cancer Drug Sales and Growth Rate (2011-2016)
8.1.2 Southeast Asia Kidney Cancer Drug Revenue and Growth Rate (2011-2016)
8.1.3 Southeast Asia Kidney Cancer Drug Sales Price Trend (2011-2016)
8.2 Southeast Asia Kidney Cancer Drug Sales and Market Share by Manufacturers
8.3 Southeast Asia Kidney Cancer Drug Sales and Market Share by Type
8.4 Southeast Asia Kidney Cancer Drug Sales and Market Share by Application
9 Global Kidney Cancer Drug Manufacturers Analysis
9.1 Bayer
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Kidney Cancer Drug Product Type, Application and Specification
9.1.2.1 Type I
9.1.2.2 Type II
9.1.3 Bayer Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
9.1.4 Main Business/Business Overview
9.2 F. Hoffmann-La Roche
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 120 Product Type, Application and Specification
9.2.2.1 Type I
9.2.2.2 Type II
9.2.3 F. Hoffmann-La Roche Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
9.2.4 Main Business/Business Overview
9.3 GlaxoSmithKline
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 145 Product Type, Application and Specification
9.3.2.1 Type I
9.3.2.2 Type II
9.3.3 GlaxoSmithKline Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
9.3.4 Main Business/Business Overview
9.4 Novartis
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Sep Product Type, Application and Specification
9.4.2.1 Type I
9.4.2.2 Type II
9.4.3 Novartis Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
9.4.4 Main Business/Business Overview
9.5 Pfizer
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Product Type, Application and Specification
9.5.2.1 Type I
9.5.2.2 Type II
9.5.3 Pfizer Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
9.5.4 Main Business/Business Overview
9.6 Abbott Laboratories
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Million USD Product Type, Application and Specification
9.6.2.1 Type I
9.6.2.2 Type II
9.6.3 Abbott Laboratories Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
9.6.4 Main Business/Business Overview
9.7 Active Biotech
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Pharmaceuticals Product Type, Application and Specification
9.7.2.1 Type I
9.7.2.2 Type II
9.7.3 Active Biotech Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
9.7.4 Main Business/Business Overview
9.8 Amgen
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Product Type, Application and Specification
9.8.2.1 Type I
9.8.2.2 Type II
9.8.3 Amgen Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
9.8.4 Main Business/Business Overview
9.9 Argos Therapeutics
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Product Type, Application and Specification
9.9.2.1 Type I
9.9.2.2 Type II
9.9.3 Argos Therapeutics Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
9.9.4 Main Business/Business Overview
9.10 ArQule
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Product Type, Application and Specification
9.10.2.1 Type I
9.10.2.2 Type II
9.10.3 ArQule Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
9.10.4 Main Business/Business Overview
9.11 AVEO Pharmaceuticals
9.12 Bionomics
9.13 Bristol-Myers Squibb
9.14 Cerulean Pharma
9.15 Exelixis
9.16 Genentech
9.17 immatics biotechnologies
9.18 Immunicum
9.19 Ono Pharmaceutical
9.20 Onyx Therapeutics
9.21 Oxford BioMedica
9.22 Prometheus Laboratories
9.23 Seattle Genetics
9.24 Taiwan Liposome
9.25 TRACON Pharmaceuticals
9.26 Wilex
10 Kidney Cancer Drug Maufacturing Cost Analysis
10.1 Kidney Cancer Drug Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Kidney Cancer Drug
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Kidney Cancer Drug Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Kidney Cancer Drug Major Manufacturers in 2015
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Kidney Cancer Drug Market Forecast (2016-2021)
14.1 Global Kidney Cancer Drug Sales, Revenue Forecast (2016-2021)
14.2 Global Kidney Cancer Drug Sales Forecast by Regions (2016-2021)
14.3 Global Kidney Cancer Drug Sales Forecast by Type (2016-2021)
14.4 Global Kidney Cancer Drug Sales Forecast by Application (2016-2021)
15 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer
List of Tables and Figures
Figure Picture of Kidney Cancer Drug
Table Classification of Kidney Cancer Drug
Figure Global Sales Market Share of Kidney Cancer Drug by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Kidney Cancer Drug
Figure Global Sales Market Share of Kidney Cancer Drug by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure USA Kidney Cancer Drug Revenue and Growth Rate (2011-2021)
Figure China Kidney Cancer Drug Revenue and Growth Rate (2011-2021)
Figure Europe Kidney Cancer Drug Revenue and Growth Rate (2011-2021)
Figure Japan Kidney Cancer Drug Revenue and Growth Rate (2011-2021)
Figure India Kidney Cancer Drug Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Kidney Cancer Drug Revenue and Growth Rate (2011-2021)
Figure Global Kidney Cancer Drug Sales and Growth Rate (2011-2021)
Figure Global Kidney Cancer Drug Revenue and Growth Rate (2011-2021)
Table Global Kidney Cancer Drug Sales of Key Manufacturers (2011-2016)
Table Global Kidney Cancer Drug Sales Share by Manufacturers (2011-2016)
Figure 2015 Kidney Cancer Drug Sales Share by Manufacturers
Figure 2016 Kidney Cancer Drug Sales Share by Manufacturers
Table Global Kidney Cancer Drug Revenue by Manufacturers (2011-2016)
Table Global Kidney Cancer Drug Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Kidney Cancer Drug Revenue Share by Manufacturers
Table 2016 Global Kidney Cancer Drug Revenue Share by Manufacturers
Table Global Kidney Cancer Drug Sales and Market Share by Type (2011-2016)
Table Global Kidney Cancer Drug Sales Share by Type (2011-2016)
Figure Sales Market Share of Kidney Cancer Drug by Type (2011-2016)
Figure Global Kidney Cancer Drug Sales Growth Rate by Type (2011-2016)
Table Global Kidney Cancer Drug Revenue and Market Share by Type (2011-2016)
Table Global Kidney Cancer Drug Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Kidney Cancer Drug by Type (2011-2016)
Figure Global Kidney Cancer Drug Revenue Growth Rate by Type (2011-2016)
Table Global Kidney Cancer Drug Sales and Market Share by Regions (2011-2016)
Table Global Kidney Cancer Drug Sales Share by Regions (2011-2016)
Figure Sales Market Share of Kidney Cancer Drug by Regions (2011-2016)
Figure Global Kidney Cancer Drug Sales Growth Rate by Regions (2011-2016)
Table Global Kidney Cancer Drug Revenue and Market Share by Regions (2011-2016)
Table Global Kidney Cancer Drug Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Kidney Cancer Drug by Regions (2011-2016)
Figure Global Kidney Cancer Drug Revenue Growth Rate by Regions (2011-2016)
Table Global Kidney Cancer Drug Sales and Market Share by Application (2011-2016)
Table Global Kidney Cancer Drug Sales Share by Application (2011-2016)
Figure Sales Market Share of Kidney Cancer Drug by Application (2011-2016)
Figure Global Kidney Cancer Drug Sales Growth Rate by Application (2011-2016)
Figure USA Kidney Cancer Drug Sales and Growth Rate (2011-2016)
Figure USA Kidney Cancer Drug Revenue and Growth Rate (2011-2016)
Figure USA Kidney Cancer Drug Sales Price Trend (2011-2016)
Table USA Kidney Cancer Drug Sales by Manufacturers (2011-2016)
Table USA Kidney Cancer Drug Market Share by Manufacturers (2011-2016)
Table USA Kidney Cancer Drug Sales by Type (2011-2016)
Table USA Kidney Cancer Drug Market Share by Type (2011-2016)
Table USA Kidney Cancer Drug Sales by Application (2011-2016)
Table USA Kidney Cancer Drug Market Share by Application (2011-2016)
Figure China Kidney Cancer Drug Sales and Growth Rate (2011-2016)
Figure China Kidney Cancer Drug Revenue and Growth Rate (2011-2016)
Figure China Kidney Cancer Drug Sales Price Trend (2011-2016)
Table China Kidney Cancer Drug Sales by Manufacturers (2011-2016)
Table China Kidney Cancer Drug Market Share by Manufacturers (2011-2016)
Table China Kidney Cancer Drug Sales by Type (2011-2016)
Table China Kidney Cancer Drug Market Share by Type (2011-2016)
Table China Kidney Cancer Drug Sales by Application (2011-2016)
Table China Kidney Cancer Drug Market Share by Application (2011-2016)
Figure Europe Kidney Cancer Drug Sales and Growth Rate (2011-2016)
Figure Europe Kidney Cancer Drug Revenue and Growth Rate (2011-2016)
Figure Europe Kidney Cancer Drug Sales Price Trend (2011-2016)
Table Europe Kidney Cancer Drug Sales by Manufacturers (2011-2016)
Table Europe Kidney Cancer Drug Market Share by Manufacturers (2011-2016)
Table Europe Kidney Cancer Drug Sales by Type (2011-2016)
Table Europe Kidney Cancer Drug Market Share by Type (2011-2016)
Table Europe Kidney Cancer Drug Sales by Application (2011-2016)
Table Europe Kidney Cancer Drug Market Share by Application (2011-2016)
Figure Japan Kidney Cancer Drug Sales and Growth Rate (2011-2016)
Figure Japan Kidney Cancer Drug Revenue and Growth Rate (2011-2016)
Figure Japan Kidney Cancer Drug Sales Price Trend (2011-2016)
Table Japan Kidney Cancer Drug Sales by Manufacturers (2011-2016)
Table Japan Kidney Cancer Drug Market Share by Manufacturers (2011-2016)
Table Japan Kidney Cancer Drug Sales by Type (2011-2016)
Table Japan Kidney Cancer Drug Market Share by Type (2011-2016)
Table Japan Kidney Cancer Drug Sales by Application (2011-2016)
Table Japan Kidney Cancer Drug Market Share by Application (2011-2016)
Figure India Kidney Cancer Drug Sales and Growth Rate (2011-2016)
Figure India Kidney Cancer Drug Revenue and Growth Rate (2011-2016)
Figure India Kidney Cancer Drug Sales Price Trend (2011-2016)
Table India Kidney Cancer Drug Sales by Manufacturers (2011-2016)
Table India Kidney Cancer Drug Market Share by Manufacturers (2011-2016)
Table India Kidney Cancer Drug Sales by Type (2011-2016)
Table India Kidney Cancer Drug Market Share by Type (2011-2016)
Table India Kidney Cancer Drug Sales by Application (2011-2016)
Table India Kidney Cancer Drug Market Share by Application (2011-2016)
Figure Southeast Asia Kidney Cancer Drug Sales and Growth Rate (2011-2016)
Figure Southeast Asia Kidney Cancer Drug Revenue and Growth Rate (2011-2016)
Figure Southeast Asia Kidney Cancer Drug Sales Price Trend (2011-2016)
Table Southeast Asia Kidney Cancer Drug Sales by Manufacturers (2011-2016)
Table Southeast Asia Kidney Cancer Drug Market Share by Manufacturers (2011-2016)
Table Southeast Asia Kidney Cancer Drug Sales by Type (2011-2016)
Table Southeast Asia Kidney Cancer Drug Market Share by Type (2011-2016)
Table Southeast Asia Kidney Cancer Drug Sales by Application (2011-2016)
Table Southeast Asia Kidney Cancer Drug Market Share by Application (2011-2016)
Table Bayer Basic Information List
Table Bayer Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer Kidney Cancer Drug Global Market Share (2011-2016)
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure F. Hoffmann-La Roche Kidney Cancer Drug Global Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Kidney Cancer Drug Global Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Kidney Cancer Drug Global Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Kidney Cancer Drug Global Market Share (2011-2016)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Laboratories Kidney Cancer Drug Global Market Share (2011-2016)
Table Active Biotech Basic Information List
Table Active Biotech Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Active Biotech Kidney Cancer Drug Global Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Amgen Kidney Cancer Drug Global Market Share (2011-2016)
Table Argos Therapeutics Basic Information List
Table Argos Therapeutics Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Argos Therapeutics Kidney Cancer Drug Global Market Share (2011-2016)
Table ArQule Basic Information List
Table ArQule Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure ArQule Kidney Cancer Drug Global Market Share (2011-2016)
Table AVEO Pharmaceuticals Basic Information List
Table AVEO Pharmaceuticals Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure AVEO Pharmaceuticals Kidney Cancer Drug Global Market Share (2011-2016)
Table Bionomics Basic Information List
Table Bionomics Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bionomics Kidney Cancer Drug Global Market Share (2011-2016)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bristol-Myers Squibb Kidney Cancer Drug Global Market Share (2011-2016)
Table Cerulean Pharma Basic Information List
Table Cerulean Pharma Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Cerulean Pharma Kidney Cancer Drug Global Market Share (2011-2016)
Table Exelixis Basic Information List
Table Exelixis Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Exelixis Kidney Cancer Drug Global Market Share (2011-2016)
Table Genentech Basic Information List
Table Genentech Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Genentech Kidney Cancer Drug Global Market Share (2011-2016)
Table immatics biotechnologies Basic Information List
Table immatics biotechnologies Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure immatics biotechnologies Kidney Cancer Drug Global Market Share (2011-2016)
Table Immunicum Basic Information List
Table Immunicum Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Immunicum Kidney Cancer Drug Global Market Share (2011-2016)
Table Ono Pharmaceutical Basic Information List
Table Ono Pharmaceutical Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Ono Pharmaceutical Kidney Cancer Drug Global Market Share (2011-2016)
Table Onyx Therapeutics Basic Information List
Table Onyx Therapeutics Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Onyx Therapeutics Kidney Cancer Drug Global Market Share (2011-2016)
Table Oxford BioMedica Basic Information List
Table Oxford BioMedica Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Oxford BioMedica Kidney Cancer Drug Global Market Share (2011-2016)
Table Prometheus Laboratories Basic Information List
Table Prometheus Laboratories Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Prometheus Laboratories Kidney Cancer Drug Global Market Share (2011-2016)
Table Seattle Genetics Basic Information List
Table Seattle Genetics Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Seattle Genetics Kidney Cancer Drug Global Market Share (2011-2016)
Table Taiwan Liposome Basic Information List
Table Taiwan Liposome Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Taiwan Liposome Kidney Cancer Drug Global Market Share (2011-2016)
Table TRACON Pharmaceuticals Basic Information List
Table TRACON Pharmaceuticals Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure TRACON Pharmaceuticals Kidney Cancer Drug Global Market Share (2011-2016)
Table Wilex Basic Information List
Table Wilex Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Wilex Kidney Cancer Drug Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Kidney Cancer Drug
Figure Manufacturing Process Analysis of Kidney Cancer Drug
Figure Kidney Cancer Drug Industrial Chain Analysis
Table Raw Materials Sources of Kidney Cancer Drug Major Manufacturers in 2015
Table Major Buyers of Kidney Cancer Drug
Table Distributors/Traders List
Figure Global Kidney Cancer Drug Sales and Growth Rate Forecast (2016-2021)
Figure Global Kidney Cancer Drug Revenue and Growth Rate Forecast (2016-2021)
Table Global Kidney Cancer Drug Sales Forecast by Regions (2016-2021)
Table Global Kidney Cancer Drug Sales Forecast by Type (2016-2021)
Table Global Kidney Cancer Drug Sales Forecast by Application (2016-2021)
  • Global Human Growth Hormone (hGH) Market Research Report 2017
    Published: 14-Dec-2017        Price: US 2900 Onwards        Pages: 100
    In this report, the global Human Growth Hormone (hGH) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Human Growth Hormone (hGH) in these regions, from 2012 to 2022 (forecast), covering - North America - Europe......
  • Global Acromegaly Treatment Market Size, Status and Forecast 2022
    Published: 14-Dec-2017        Price: US 3300 Onwards        Pages: 99
    This report studies the global Acromegaly Treatment market, analyzes and researches the Acromegaly Treatment development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Pfizer Inc - Chiasma Inc - Novartis AG - Ipsen Biopharmaceuticals Inc - Wockhardt Ltd - Troikaa Pharmaceuticals Limited - VHB Life Sciences Limited - GlaxoSmithKline plc ......
  • Global Acyl CoA Desaturase Sales Market Report 2017
    Published: 14-Dec-2017        Price: US 4000 Onwards        Pages: 109
    In this report, the global Acyl CoA Desaturase market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Acyl CoA Desaturase for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japa......
  • Global Enteric Softgel Capsules Market Research Report 2017
    Published: 14-Dec-2017        Price: US 2900 Onwards        Pages: 106
    In this report, the global Enteric Softgel Capsules market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Enteric Softgel Capsules in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - ......
  • Global Non-Insulin Therapies for Diabetes Market Professional Survey Report 2017
    Published: 14-Dec-2017        Price: US 3500 Onwards        Pages: 116
    This report studies Non-Insulin Therapies for Diabetes in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - GSK - Eli Lilly - Sumitomo Dainippon Pharma - Int......
  • Global Combination Vaccine Sales Market Report 2017
    Published: 14-Dec-2017        Price: US 4000 Onwards        Pages: 105
    In this report, the global Combination Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (Units), revenue (Million USD), market share and growth rate of Combination Vaccine for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japa......
  • Global Axial Spondyloarthritis Drugs Sales Market Report 2017
    Published: 14-Dec-2017        Price: US 4000 Onwards        Pages: 104
    In this report, the global Axial Spondyloarthritis Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Axial Spondyloarthritis Drugs for these regions, from 2012 to 2022 (forecast), covering - United States - China - ......
  • Global Dermatomyositis Drug Sales Market Report 2017
    Published: 14-Dec-2017        Price: US 4000 Onwards        Pages: 116
    In this report, the global Dermatomyositis Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Dermatomyositis Drug for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Ja......
  • Global Erythropoietin Drugs Sales Market Report 2017
    Published: 14-Dec-2017        Price: US 4000 Onwards        Pages: 102
    In this report, the global Erythropoietin Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K ML), revenue (Million USD), market share and growth rate of Erythropoietin Drugs for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Jap......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs